AMICUS THERAPEUTICS, INC.
Develops advanced therapies for rare lysosomal storage disorders.
FOLD | NDAQ
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 47 HULFISH STREET, 8542 PRINCETON
- Website:
- https://www.amicusrx.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Amicus Therapeutics, Inc. is a global, patient-dedicated biotechnology company focused on discovering, developing, and delivering high-quality medicines for people living with rare and devastating genetic diseases. The company leverages innovative technology platforms to create advanced therapies, with a particular focus on pharmacological chaperones and enzyme replacement therapies. Its primary areas of development target lysosomal storage disorders, including Fabry disease and Pompe disease, aiming to provide novel treatments for patients with unmet medical needs.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all AMICUS THERAPEUTICS, INC. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for AMICUS THERAPEUTICS, INC.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for AMICUS THERAPEUTICS, INC. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
